| Innovative approaches to increase access to medicines in developing countries H Stevens, I Huys Frontiers in medicine 4, 218, 2017 | 62 | 2017 |
| Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review R Janssens, I Huys, E van Overbeeke, C Whichello, S Harding, J Kübler, ... BMC medical informatics and decision making 19, 1-16, 2019 | 45 | 2019 |
| Perspectives and opportunities for precompetitive public–private partnerships in the biomedical sector H Stevens, G Van Overwalle, B Van Looy, I Huys Biotechnology Law Report 32 (3), 131-139, 2013 | 38 | 2013 |
| Patient preferences in the medical product life cycle: what do stakeholders think? Semi-structured qualitative interviews in Europe and the USA R Janssens, S Russo, E van Overbeeke, C Whichello, S Harding, J Kübler, ... The Patient-Patient-Centered Outcomes Research 12, 513-526, 2019 | 34 | 2019 |
| Patient preferences for multiple myeloma treatments: a multinational qualitative study R Janssens, T Lang, A Vallejo, J Galinsky, A Plate, K Morgan, ... Frontiers in medicine 8, 686165, 2021 | 25 | 2021 |
| Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions E van Overbeeke, S Michelsen, M Toumi, H Stevens, M Trusheim, I Huys, ... Drug discovery today 26 (2), 399-415, 2021 | 24 | 2021 |
| Intellectual property policies in early-phase research in public–private partnerships H Stevens, G Van Overwalle, B Van Looy, I Huys Nature biotechnology 34 (5), 504-510, 2016 | 23 | 2016 |
| Patient involvement in the lifecycle of medicines according to belgian stakeholders: the gap between theory and practice R Janssens, E Van Overbeeke, L Verswijvel, L Meeusen, C Coenegrachts, ... Frontiers in medicine 5, 285, 2018 | 17 | 2018 |
| Vaccines: accelerating innovation and access H Stevens, K Debackere, M Goldman, RT Mahoney, P Stevens, I Huys Global Challenges Report, World Intellectual Property Organization (WIPO), 2017 | 14 | 2017 |
| From opioid pain management to opioid crisis in the USA: how can public-private partnerships help? L Bolliger, H Stevens Frontiers in medicine 6, 106, 2019 | 13 | 2019 |
| Innovative medicines initiative (IMI) case study analysis reveals the true added value of early-phase public-private partnerships (PPPs) H Stevens, G Van Overwalle, B Van Looy, I Huys Biotechnology law report 34 (4), 153-165, 2015 | 8 | 2015 |
| TRIPS to where? A narrative review of the empirical literature on intellectual property licensing models to promote global diffusion of essential medicines S Mermelstein, H Stevens Pharmaceutics 14 (1), 48, 2021 | 6 | 2021 |
| Improving patient involvement in the lifecycle of medicines: insights from the EUPATI BE survey L Grine, R Janssens, E Van Overbeeke, D Derijcke, M Silva, B Delys, ... Frontiers in Medicine 7, 36, 2020 | 4 | 2020 |
| What matters most to patients with multiple myeloma? A Pan-European patient preference study R Janssens, T Lang, A Vallejo, J Galinsky, K Morgan, A Plate, ... Frontiers in oncology 12, 1027353, 2022 | 2 | 2022 |
| PCN297 Understanding what matters to multiple myeloma patients: a qualitative study R Janssens, K Morgan, R Silvennoinen, D Coriu, S Badelita, R Irimia, ... Value in Health 23, S474-S475, 2020 | 2 | 2020 |
| Public-Private Partnerships as Drivers of Innovation in Healthcare H Stevens, M Goldman Frontiers Media SA, 2020 | 2 | 2020 |
| Intellectual property in early-phase research public-private partnerships in the biomedical sector H Stevens, I Huys Cambridge Handbook of Public–Private Partnerships, Intellectual Property …, 2018 | 2 | 2018 |
| The Role of Intellectual Property in (Precompetitive) Public-Private Partnerships in the Biomedical Sector H Stevens | 2 | 2015 |
| Patient preference studies in drug development and evaluation: views from European drug regulators R Janssens, J Pinoy, D Postmus, H Hillege, S Vamvakas, N Bere, ... DIA EUROPE, Location: Brussels, 2022 | 1 | 2022 |
| Patient Preferences in Drug Development and Evaluation: Issues and Recommendations R Janssens | 1 | 2021 |
